Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q2 2023 · 10-Q
Revenue$10.69B$10.69B−2.6% vs Q2 2022 Net Income$1.36B$1.36B−18.3% vs Q2 2022 EPS Diluted$3.51$3.51−16.8% vs Q2 2022 Operating Income$1,578,000,000−21.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,256,000,000+22.9% Margins · derivedOperating margin14.8%−3.5 pt vs Q2 2022
Net margin12.7%−2.5 pt vs Q2 2022
ended Jul 1, 2023 · filed Aug 4, 2023 · 34 d after period end